AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildakind Met 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Sentosa Geigy (India) Labs Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildakind Met 500mg/50mg Tablet

Metformin/pioglitazone 500mg/50mg tablets effectively manage elevated blood glucose in patients with type 2 diabetes. This dual-action medication mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may lessen the probability of cardiovascular events. Metformin/pioglitazone may be administered as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Ingesting the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit and discontinuation should only occur under medical supervision. Effective blood sugar regulation helps prevent future complications. Continued adherence to the prescribed dietary and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported adverse effects include diarrhea, nausea, emesis, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; proper recognition and management of hypoglycemia are essential. This medication is not universally appropriate. Prior to commencing treatment, disclose any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption to your physician. Pregnant or lactating individuals require medical consultation before initiating therapy. Potential drug interactions necessitate complete disclosure of all medications to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Renal function and blood glucose levels will be monitored regularly throughout treatment.

Primary Ingredients of Vildakind Met 500mg/50mg Tablet

No text was provided to rewrite.

Uses of Vildakind Met 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildakind Met 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vildakind Met 500mg/50mg tablets should be administered with food.

Common Side effects of Vildakind Met 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildakind Met 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vildakind Met 500mg/50mg tablets should be administered with a meal.

How Vildakind Met 500mg/50mg Tablet works:

Metformin and vildagliptin 500mg/50mg tablets, brand name Vildakind, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Vildakind Met 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnant women may experience adverse effects from Vildakind Met 500mg/50mg Tablets. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the risks and advantages before prescribing this medication. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Vildakind Met 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildakind Met 500mg/50mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Vildakind Met 500mg/50mg tablets due to potential safety concerns. Physician consultation is advised.

What if you forget to take Vildakind Met 500mg/50mg Tablet :

Should you forget to take your Vildakind Met 500mg/50mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Vildakind Met 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Vildakind Met 500mg/50mg Tablet

Vildakind Met 500mg/50mg Tablets rarely cause hypoglycemia (low blood sugar) by themselves. However, insufficient caloric intake while using this medication may lead to hypoglycemia, manifested as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildakind Met 500mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Vildakind Met 500mg/50mg Tablets are contraindicated in patients allergic to any component or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildakind Met 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Vildakind Met 500mg/50mg Tablets can, rarely, cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Vildakind Met 500mg/50mg tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological issues.
Vildakind Met 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper use, common side effects may include nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia) if taken with insulin or sulphonylurea. Report any persistent side effects to your physician.
Vildakind Met 500mg/50mg ...
381
MRP 441
13% off